Key Events This Week
23 Mar: Stock hits 52-week low at Rs.135 amid broad market weakness
24 Mar: Downgrade to Strong Sell by MarketsMOJO due to worsening fundamentals and technicals
27 Mar: New 52-week low at Rs.129.15 as downtrend continues
27 Mar Close: Week ends at Rs.129.65, down 7.43%

Nath Bio-Genes Falls to 52-Week Low of Rs 129.15 as Sell-Off Deepens
2026-03-27 11:22:16A sharp decline in Nath Bio-Genes (India) Ltd has pushed the stock to a fresh 52-week low of Rs 129.15 on 27 Mar 2026, marking a significant 5% intraday drop and extending the recent downtrend despite a brief two-day rally.
Read full news article
Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
2026-03-24 08:31:18Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has been downgraded from a Sell to a Strong Sell rating as of 23 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, weak long-term fundamentals, and a cautious valuation outlook, signalling heightened risks for investors amid ongoing market pressures.
Read full news article
Nath Bio-Genes Falls to 52-Week Low of Rs 135 as Sell-Off Deepens
2026-03-23 13:13:53A sharp decline of 3.61% today dragged Nath Bio-Genes (India) Ltd to a fresh 52-week low of Rs 135, extending a downward trajectory that has seen the stock underperform the broader market significantly over the past year.
Read full news article
Nath Bio-Genes (India) Ltd Upgraded to Sell Amid Mixed Technicals and Weak Fundamentals
2026-03-17 08:27:14Nath Bio-Genes (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The company’s micro-cap status, flat recent financial performance, and subdued institutional interest continue to weigh on sentiment, while modest improvements in technical indicators have prompted a cautious reassessment of its market stance.
Read full news article
Nath Bio-Genes (India) Ltd is Rated Strong Sell
2026-03-16 10:10:47Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 16 March 2026, providing an up-to-date view of the company’s position in the market.
Read full news articleNath Bio-Genes Falls 3.97%: 2 Key Factors Behind the Weekly Decline
2026-03-14 17:12:53
Key Events This Week
2 Mar: Stock opens week at Rs.144.30, down 3.77%
4 Mar: Hits 52-week low at Rs.137.95 amid continued downtrend
5 Mar: Downgraded to Strong Sell by MarketsMOJO
6 Mar: Week closes at Rs.144.00, down 0.31% on day

Nath Bio-Genes (India) Ltd Falls to 52-Week Low Amid Continued Underperformance
2026-03-09 12:39:22Nath Bio-Genes (India) Ltd touched a fresh 52-week low of Rs.136 on 9 Mar 2026, marking a significant decline amid ongoing challenges reflected in its financial performance and market positioning. The stock’s fall comes despite a brief two-day rally, underscoring persistent pressures within the Other Agricultural Products sector.
Read full news article
Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
2026-03-05 08:19:30Nath Bio-Genes (India) Ltd has been downgraded from a Sell to a Strong Sell rating as of 4 March 2026, reflecting deteriorating technical indicators, flat financial performance, and waning investor confidence. The company’s Mojo Score has dropped to 26.0, signalling significant caution for investors amid persistent underperformance relative to benchmarks and peers.
Read full news articleNath Bio-Genes (India) Limited - Other General Purpose
26-Nov-2019 | Source : NSENath Bio-Genes (India) Limited has informed the Exchange regarding Related Party Transaction for the half year ended September 30, 2019.
Nath Bio-Genes (India) Limited - Investor Presentation
04-Nov-2019 | Source : NSENath Bio-Genes (India) Limited has informed the Exchange regarding Investor Presentation on unaudited financial results for the period ended 30th sep 2019
Nath Bio-Genes (India) Limited - Updates
30-Oct-2019 | Source : NSENath Bio-Genes (India) Limited has informed the Exchange regarding 'Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.'.
Corporate Actions
No Upcoming Board Meetings
Nath Bio-Genes (India) Ltd has declared 20% dividend, ex-date: 14 Aug 25
No Splits history available
No Bonus history available
No Rights history available






